Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives
Open Access
- 1 August 2019
- journal article
- review article
- Published by Taylor & Francis in Nature and Science of Sleep
- Vol. ume 11, 97-111
Abstract
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease inevitably leading to generalized muscle weakness and premature death. Sleep disturbances are extremely common in patients with ALS and substantially add to the burden of disease for both patients and caregivers. Disruption of sleep can be caused by physical symptoms, such as muscle cramps, pain, reduced mobility, spasticity, mucus retention, and restless legs syndrome. In addition, depression and anxiety may lead to significant insomnia. In a small subset of patients, rapid eye movement (REM) sleep behavioral disorder may be present, reflecting neurodegeneration of central nervous system pathways which are involved in REM sleep regulation. With regard to overall prognosis, sleep-disordered breathing (SDB) and nocturnal hypoventilation (NH) are of utmost importance, particularly because NH precedes respiratory failure. Timely mechanical ventilation is one of the most significant therapeutic measures to prolong life span in ALS, and transcutaneous capnometry is superior to pulse oxymetry to detect NH early. In addition, it has been shown that in patients on home ventilatory support, survival time depends on whether normocapnia, normoxia, and elimination of apneic events during sleep can be reliably achieved. Several studies have investigated sleep patterns and clinical determinants of sleep disruption in ALS, but exact prevalence numbers are unknown. Thus, constant awareness for sleep-related symptoms is appropriate. Since no curative treatment can be offered to affected patients, sleep complaints should be thoroughly investigated in order to identify any treatable etiology and improve or stabilize quality of life as much as possible. The use of hypnotics should be confined to palliation during the terminal phase and refractory insomnia in earlier stages of the disease, taking into account that most compounds potentially aggravate SDB.Keywords
This publication has 100 references indexed in Scilit:
- Prognosis and epidemiology of amyotrophic lateral sclerosisNeurology Clinical Practice, 2013
- Normative EMG Values during REM Sleep for the Diagnosis of REM Sleep Behavior DisorderSLEEP, 2012
- Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based studyJournal of Neurology, Neurosurgery & Psychiatry, 2011
- EFNS guidelines on the Clinical Management of Amyotrophic Lateral Sclerosis (MALS) – revised report of an EFNS task forceEuropean Journal of Neurology, 2011
- REM sleep behavior disorder in a patient with frontotemporal dementiaNeurological Sciences, 2011
- The neuronal network responsible for paradoxical sleep and its dysfunctions causing narcolepsy and rapid eye movement (REM) behavior disorderSleep Medicine Reviews, 2011
- Restless legs syndrome in patients with amyotrophic lateral sclerosisMovement Disorders, 2010
- The Borg dyspnoea score: a relevant clinical marker of inspiratory muscle weakness in amyotrophic lateral sclerosisEuropean Respiratory Journal, 2009
- Effect of non‐invasive ventilation on survival, quality of life, respiratory function and cognition: A review of the literatureAmyotrophic Lateral Sclerosis, 2006
- Evaluating the quality of life of patients with restless legs syndromeClinical Therapeutics, 2004